143
U.S. FDA
© Siem
ens AG 2003
, C
:\Siem
ens\
DTP-
Satz\Produkte\C75
_Arie
s_
1\Output\FUG
\C75_
FU
G_FCC_
us
-en_0506
08_te\STD_
FCC
_FDA.fm
Tem
plate: X75
, Version 2.1; VAR
Langua
ge: am;
VAR issue
date: 0505
24
right page (143)
of C75 FCC, us-en FUG am, (09.06.2005, 08:40)
• World Health Organization (WHO)
International Commission on
Non-Ionizing Radiation Protection
(select Qs & As):
www.who.int/emf
• United Kingdom, National Radio-
logical Protection Board:
www.nrpb.org.uk
• Cellular Telecommunications In-
dustry Association (CTIA):
www.wow-com.com
• U.S. Food and Drug Administra-
tion (FDA) Center for devices and
Radiological Health:
www.fda.gov/cdhr/consumer/
1
Muscat et al. Epidemiological Study of
Cellular Telephone Use and Malignant Brain
Tumors. In: State of the Science Sympo-
sium; 1999 June 20; Long Beach, California.
2
Tice et al. Tests of mobile phone signals for
activity in genotoxicity and other laboratory
assays. In: Annual Meeting of the Environ-
mental Mutagen Society; March 29, 1999,
Washington, DC; and personal communica-
tion, unpublished results.
3
Preece, AW, Iwi, G, Davies-Smith, A,
Wesnes, K, Butler, S, Lim, E, and Varey, A.
Effect of a 915- MHz simulated mobile
phone signal on cognitive function in man.
Int. J. Radiat. Biol., April 8, 1999.
4
Hardell, L, Nasman, A, Pahlson, A,
Hallquist, A and Mild, KH. Use of cellular
telephones and the risk for brain tumors;
a case-control study. Int. J. Oncol, 15:
113-116, 1999.